(Q33559116)

English

Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study

scientific article

Statements

Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study (English)
17 September 2012
6058-6064

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit